Targeting once-daily intravenous busulfan in combination with fludarabine before allogeneic hematopoietic cell transplantation.
Jenke
A
A
Freiberg-Richter
J
J
Johne
C
C
Knoth
H
H
Schleyer
E
E
Ehninger
G
G
Bornhäuser
M
M
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002066:Busulfan / Q000008:administration & dosage / Q000097:blood / Q000493:pharmacokinetics*; D004334:Drug Administration Schedule; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D010599:Pharmacokinetics; D014184:Transplantation, Homologous; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives*
D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine